AF64394

CAS No. 1637300-25-4

AF64394( —— )

Catalog No. M21599 CAS No. 1637300-25-4

AF64394 is a selective inverse agonist of GPR3(pIC50 : 7.3).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 110 Get Quote
10MG 177 Get Quote
25MG 375 Get Quote
50MG 557 Get Quote
100MG 791 Get Quote
500MG 1611 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AF64394
  • Note
    Research use only, not for human use.
  • Brief Description
    AF64394 is a selective inverse agonist of GPR3(pIC50 : 7.3).
  • Description
    AF64394 is a selective inverse agonist of GPR3(pIC50 : 7.3).
  • In Vitro
    AF64394 is a GPR3 inverse agonist, with a pIC50 of 7.3. AF34394 and related compounds are only of modest potency and are relatively lipophilic (e.g., AF34394 clogP=5.2, LLE=2.1, and 14b clog P=3.1 and LLE=3.2) the series shows promising SAR and represents an excellent start point for further optimization.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GPR3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1637300-25-4
  • Formula Weight
    393.87
  • Molecular Formula
    C21H20ClN5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (317.36 mM)
  • SMILES
    CC(C)Oc1cc(Cl)ccc1CNc1cc(nc2ncnn12)-c1ccccc1
  • Chemical Name
    (4-Chloro-2-isopropoxy-benzyl)-(5-phenyl-[124]triazolo[15-a]pyrimidin-7-yl)-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jensen T et al. The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function. Bioorg Med Chem Lett. 2014 Nov 15;24(22):5195-8.
molnova catalog
related products
  • HBC620 B

    HBC620 shows brightly fluoresced in the Pepper bound state and can be visualize RNA dynamics in live cells. HBC620 is a HBC-like fluorophore.

  • Biotin-MBP(94 - 102)

    Biotin-MBP(94 - 102)

  • GSK-25

    GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).